GLP-1 receptors are expressed in reward-related regions, such as the nucleus accumbens (NAc) and ventral tegmental area (VTA), where they influence dopaminergic signaling [43]
Rethinking Risk Thresholds in Diabetes Care May 12, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,139 views A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication
Maintenance therapy has a different approach, where you take 100-200 mcg once a month
Some may experience temporary nasal irritation after use
The absence of a formal contraindication reflects the fact that IBS itself is not a single disease with uniform pathophysiology, but rather a spectrum of symptoms that vary considerably between individuals
A numbing cream is used to minimise discomfort, and most people find the treatment manageable